Senior Research Scientist Kevin Good weighs in on the debate about whether or not to wear gloves when handling explosive materials for training.
The Intel chip vulnerability that has made recent headlines is a problem that will likely have lasting implications.
Antibiotic-resistant pathogens are on the rise. Why don’t we have more new antibiotics in the pipeline to combat them?
After an exhaustive 19-month research project, massively parallel sequencing is proven to generate robust, reliable, reproducible results.
Toxicology safety testing teams are under more pressure than ever. Here are three significant innovations helping tox teams achieve more success.
To meet the need for new vaccines for chemical & biological weapons, federal agencies & private companies must work together to overcome barriers.
Massively Parallel Sequencing has been the talk of DNA scientists, but now it’s closer than ever to becoming a valid asset for law enforcement.
Inside Battelle gives you an all-access pass to the incredible work of Battelle researchers.
